Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
2020
Yearly Archives: 2020
Blog
Drug Is Safe and Sometimes Works, Let All COVID-19 Patients Take It
Ronald L. Trowbridge
-
April 2, 2020
0
Blog
Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus
Raymond March
-
April 1, 2020
0
Blog
Trust Private Enterprise to Flatten the Curve
Raymond March
-
March 27, 2020
0
Blog
FDA Should Expand Options for Coronavirus Patients
Ross Marchand
-
March 26, 2020
0
Blog
The Mask Madness of Big Government
K. Lloyd Billingsley
-
March 26, 2020
0
Blog
To Battle Covid-19, Cut Regulation!
Raymond March
-
March 25, 2020
0
Blog
Favor Local Action to Combat the Coronavirus
Raymond March
-
March 19, 2020
0
Blog
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
Raymond March
-
March 6, 2020
0
Blog
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Raymond March
-
March 5, 2020
0
Blog
There’s a Wrong Way to React to a Drug Shortage—and a Right Way
Connor Norris
-
February 28, 2020
0
1
2
3
4
Page 3 of 4
